Phase I Escalation And Expansion Study Of Bemarituzumab (Fpa144) In Patients With Advanced Solid Tumors And Fgfr2b-Selected Gastroesophageal Adenocarcinoma (Vol 38, Pg 2418, 2020)
JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要